1 / 11

Aarkstore - Metastatic Breast Cancer-Global API Manufacturer

Metastatic Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Metastatic Breast Cancer. Browse full report @ http://bit.ly/1wgFgSu

JustinSterling
Download Presentation

Aarkstore - Metastatic Breast Cancer-Global API Manufacturer

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Category : Pharmaceuticals and Healthcare Aarkstore - Metastatic Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  2. Synopsis Metastatic Breast Cancer- Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Metastatic Breast Cancer. A key objective of DelveInsights report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Metastatic Breast Cancer. The Report gives insights into patents providing thepatent protection data and marketing exclusivity of all the drugs across the Metastatic Breast Cancer. Browse Complete Report – http://www.aarkstore.com/pharmaceuticals-healthcare/98049/metastatic-breast-cancer-global-api-manufacturers-marketed-and-phase-iii-drugs-landscape-2015

  3. Data Sources The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

  4. Scope  • A snapshot of the global Market therapeutics scenario for Metastatic Breast Cancer. • A review of the marketed products under prescription for Metastatic Breast Cancer, regulatory information and marketing status. • Coverage of global patent coverage and detailed commentaries on the US patent challenges.  • Graphical representation of investigational products for patent expiry and market exclusivities across the globe. • Product profiles for marketed products for Metastatic Breast Cancer with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details. • Coverage of API Manufacturers for Metastatic Breast Cancer drugs in the United States, Europe and Asian Regions with location details. • Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Metastatic Breast Cancer drugs. • Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Metastatic Breast Cancer drugs.

  5. Reasons To Buy • Evaluate the marketing status and exclusivity details of Metastatic Breast Cancer key products to exploit opportunities for generic drug development opportunities. • Identify and understand important and diverse types of therapeutics under Phase III development for Metastatic Breast Cancer. • Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Metastatic Breast Cancer. • API intelligence over marketed drugs for Metastatic Breast Cancer and gaining primary intelligence over active ingredients manufacturers across the globe. • API intelligence over leading Phase III Pipeline drugs. • Develop and design strategies by identifying the API manufacturers for Phase III Pipeline products to enhance and expand business potential and scope.

  6. Table of Content • Indication Overview • Marketed Drugs • Marketed Details of Drugs by Application Type • Marketed Details of Drugs (NDA) by Marketing Status • Marketed Details of Drugs by Patent Expiration Timeline • Active Pharmaceutical Ingredient (API) Manufacturers Assessment • API Manufacturers by United States Drug Master File (US DMF) Status • API Manufacturers by US DMF Status (Drug Specific) • API Manufacturers in Europe by Country • API Manufacturers in India by State • API Manufacturers in China by Province

  7. List of Tables • Metastatic Breast Cancer Therapeutic Market, US, Marketed Drugs by Application Type, 2015 • Metastatic Breast Cancer Therapeutic Market, US, Marketed Drugs by Marketing Status, 2015 • Metastatic Breast Cancer Therapeutic Market, US, (Year), 2015 • Metastatic Breast Cancer Marketed Drugs, API Manufacturers by US DMF Status, 2015 • Metastatic Breast Cancer Marketed Drugs, US DMF Status Drug Specific (Number), 2015 • Metastatic Breast Cancer Drugs, API Manufacturers, Europe by Country, 2015 • Metastatic Breast Cancer Drugs, API Manufacturers, India by State, 2015 • Metastatic Breast Cancer Drugs, API Manufacturers, China by Province, 2015

  8. List of Figures • Metastatic Breast Cancer Therapeutic Market, US, Marketed Drugs by Application Type (%), 2015 • Metastatic Breast Cancer Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2015 • Metastatic Breast Cancer Therapeutic Market, US, (Year), 2015 • Metastatic Breast Cancer Marketed Drugs, API Manufacturers by US DMF Status (%), 2015 • Metastatic Breast Cancer Marketed Drugs, US DMF Status Drug Specific (Number), 2015 • Metastatic Breast Cancer Drugs, API Manufacturers, Europe by Country, 2015 • Metastatic Breast Cancer Drugs, API Manufacturers, India by State, 2015 • Metastatic Breast Cancer Drugs, API Manufacturers, China by Province, 2015 • Metastatic Breast Cancer Drugs, API Manufacturers by Geography 2015

  9. Related Reports • Lung Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 • Global Patient Temperature Management Market 2015-2019 • Global Infertility Market 2015-2019 • Global Preventable Vaccines Market 2015-2019 • Global Transplantation Market 2015-2019 • Global Ultrasound Equipment Market 2015-2019 • Cystic Fibrosis Market in Europe 2015-2019 • Global Cell Culture Protein Surface Coating Market 2015-2019 • Global Infertility Market 2015-2019 • Generic Drugs Market in Japan 2015-2019

  10. Metastatic Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Published: Feb 2015 | 100 Pages Metastatic Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Metastatic Breast Cancer. Price

  11. Contact Us Office Office No. - 809, 8th Floor,B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15,CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. Telefax No: +91 22 4127 6660 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 You Can Visit http://www.aarkstore.com OR Mail us at contact@aarkstore.com Blog : http://www.aarkstore.com/blog/ Conference : http://conference.aarkstore.com/ News : http://www.aarkstore.com/news

More Related